Parasitic helminths and their beneficial impact on type 1 and type 2 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 32, Issue 3, 2016, Pages 238-250

  Berbudi, Afiat ^a,b   Ajendra, Jesuthas ^a   Wardani, Ajeng P F ^a,b   Hoerauf, Achim ^a,c   Hübner, Marc P ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b PADJADJARAN UNIVERSITY   (Indonesia)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Adipose; Diabetes; Helminth; Insulin resistance; Obesity; Regulatory

Indexed keywords

HELMINTH ANTIGEN; INSULIN; INTERLEUKIN 10; NATURAL PRODUCT; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ADIPOGENESIS; BROWN ADIPOCYTE; BROWN ADIPOSE TISSUE; CELL DESTRUCTION; CLINICAL EFFECTIVENESS; CORRELATIONAL STUDY; DIABETIC OBESITY; DIABETOGENESIS; ENERGY EXPENDITURE; EVIDENCE BASED PRACTICE; HELMINTH; HELMINTHIASIS; HUMAN; IMMUNOMODULATION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MOUSE MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PARASITE IMMUNITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THERAPY WITH HELMINTHS; ANIMAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; IMMUNOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HELMINTHS; HUMANS; IMMUNOMODULATION;

EID: 84959546039     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2673     Document Type: Review

References (101)

1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.
2. International Diabetes Federation. IDF Diabetes Atlas 6th edn. 2014 update. Brussels, Belgium, 2014.
3. International Diabetes Federation. IDF Diabetes Atlas 6th Edition. 2013.
4. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005; 97: 1679-1687. doi:10.1093/jnci/dji375.
5. Ott A, Stolk RP, van Harskamp F, Pols Hap, Hofman A, Breteler Mmb. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999; 53: 1937-1937. doi:10.1212/WNL.53.9.1937.
6. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11: 98-107. doi:10.1038/nri2925.
7. Donath MY, Ehses JA, Maedler K, et al. Mechanisms of beta-cell death in type 2 diabetes. Diabetes 2005; 54: S108-S113. doi:10.2337/diabetes.54.suppl_2.S108.
8. Yang H, Youm Y-H, Vandanmagsar B, et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol 2010; 185: 1836-1845. doi:10.4049/jimmunol.1000021.
9. Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 2003; 3: 733-744. doi:10.1038/nri1183.
10. Rook GW. Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis. Immunology 2009; 126: 3-11. doi:10.1111/j.1365-2567.2008.03007.x.
11. Hübner MP, Stocker JT, Mitre E. Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells. Immunology 2009; 127: 512-522. doi:10.1111/j.1365-2567.2008.02958.x.
12. Hübner MP, Shi Y, Torrero MN, et al. Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-β. J Immunol 2012; 188: 559-568. doi:10.4049/jimmunol.1100335.
13. Lehuen A, Diana J, Zaccone P, Cooke A. Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 2010; 10: 501-513. doi:10.1038/nri2787.
14. Wu D, Molofsky AB, Liang H-E, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011; 332: 243-247. doi:10.1126/science.1201475.
15. Aravindhan V, Mohan V, Surendar J, et al. Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83). PLoS Negl Trop Dis 2010; 4: e707. doi:10.1371/journal.pntd.0000707.
16. Chen Y, Lu J, Huang Y, et al. Association of previous schistosome infection with diabetes and metabolic syndrome: a cross-sectional study in rural China. J Clin Endocrinol Metab 2012; 98: 1-5. doi:10.1210/jc.2012-2517.
17. Hussaarts L, García-Tardón N, Beek L, et al. Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice. FASEB J 2015: 1-13. doi:10.1096/fj.14-266239.
18. WHO. Global Status Report on noncommunicable diseases 2014. Geneva: WHO, 2014.
19. Banting FG, Best CH. Pancreatic extracts. 1922. J Lab Clin Med 1990; 115: 254-272.
20. Onkamo P, Väänänen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of Type I diabetes ± the analysis of the data on published incidence trends. Diabetologia 1999; 42(12): 1395-1403.
21. Allison MJ, Pezzia A, Hasegawa I, Gerszten E. A case of hookworm infestation in a Precolumbian American. Am J Phys Anthropol 1974; 41: 103-106. doi:10.1002/ajpa.1330410113.
22. Aspöck H, Flamm H, Picher O. Intestinal parasites in human excrements from prehistoric salt-mines of the Hallstatt period (800-350 B.C.). Zentralbl Bakteriol Orig A 1973; 223: 549-558.
23. Jackson JA, Friberg IM, Little S, Bradley JE. Review series on helminths, immune modulation and the hygiene hypothesis: immunity against helminths and immunological phenomena in modern human populations: coevolutionary legacies? Immunology 2009; 126: 18-27. doi:10.1111/j.1365-2567.2008.03010.x.
24. Elliott DE, Summers RW, Weinstock JV. Helminths as governors of immune-mediated inflammation. Int J Parasitol 2007; 37: 457-464. doi:10.1016/j.ijpara.2006.12.009.
25. Stoll NR. This wormy world. 1947. J Parasitol 1999; 85: 392-396.
26. Gale Eam. A missing link in the hygiene hypothesis? Diabetologia 2002; 45: 588-594. doi:10.1007/s00125-002-0801-1.
27. Weinstock JV, Summers RW, Elliott DE, Qadir K, Urban JF, Thompson R. The possible link between de-worming and the emergence of immunological disease. J Lab Clin Med 2002; 139: 334-338.
28. Cooke A, Tonks P, Jones FM, et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol 1999; 21: 169-176.
29. Zaccone P, Fehérvári Z, Jones FM, et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 2003; 33: 1439-1449. doi:10.1002/eji.200323910.
30. Saunders KA, Raine T, Cooke A, Lawrence CE. Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect Immun 2007; 75: 397-407. doi:10.1128/IAI.00664-06.
31. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980; 29: 1-13.
32. Driver JP, Serreze DV, Chen Y-G. Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease. Semin Immunopathol 2011; 33: 67-87. doi:10.1007/s00281-010-0204-1.
33. Grzych JM, Pearce E, Cheever A, et al. Egg deposition is the major stimulus for the production of Th2 cytokines in murine Schistosomiasis mansoni. J Immunol 1991; 146: 1322-1327.
34. Brunet L, Dunne D, Pearce E. Cytokine interaction and immune responses during Schistosoma mansoni infection. Parasitol Today 1998; 14: 422-427. doi:10.1016/S0169-4758(98)01317-9.
35. Grainger JR, Smith KA, Hewitson JP, et al. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway. J Exp Med 2010; 207: 2331-2341. doi:10.1084/jem.20101074.
36. Hübner MP, Larson D, Torrero MN, et al. Anti-FcεR1 antibody injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD mice. Clin Immunol 2011; 141: 205-217. doi:10.1016/j.clim.2011.08.004.
37. Liu Q, Sundar K, Mishra PK, et al. Helminth infection can reduce insulitis and type 1 diabetes through CD25- and IL-10-independent mechanisms. Infect Immun 2009; 77: 5347-5358. doi:10.1128/IAI.01170-08.
38. Mishra PK, Patel N, Wu W, Bleich D, Gause WC. Prevention of type 1 diabetes through infection with an intestinal nematode parasite requires IL-10 in the absence of a Th2-type response. Mucosal Immunol 2013; 6: 297-308. doi:10.1038/mi.2012.71.
39. Osada Y, Yamada S, Nabeshima A, et al. Heligmosomoides polygyrus infection reduces severity of type 1 diabetes induced by multiple low-dose streptozotocin in mice via STAT6- and IL-10-independent mechanisms. Exp Parasitol 2013; 135: 388-396. doi:10.1016/j.exppara.2013.08.003.
40. Peres RS, Chiuso-Minicucci F, da Rosa LC, et al. Previous contact with Strongyloides venezuelensis contributed to prevent insulitis in MLD-STZ diabetes. Exp Parasitol 2013; 134: 183-189. doi:10.1016/j.exppara.2013.03.007.
41. Espinoza-Jiménez A, Rivera-Montoya I, Cárdenas-Arreola R, Morán L, Terrazas LI. Taenia crassiceps infection attenuates multiple low-dose streptozotocin-induced diabetes. J Biomed Biotechnol 2010; 2010: 850541. doi:10.1155/2010/850541.
42. Aravindhan V, Mohan V, Surendar J, et al. Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes. Am J Trop Med Hyg 2010; 83: 1336-1339. doi:10.4269/ajtmh.2010.10-0410.
43. Bager P, Vinkel Hansen A, Wohlfahrt J, Melbye M. Helminth infection does not reduce risk for chronic inflammatory disease in a population-based cohort study. Gastroenterology 2012; 142: 55-62. doi:10.1053/j.gastro.2011.09.046.
44. Zaccone P, Burton O, Miller N, Jones FM, Dunne DW, Cooke A. Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur J Immunol 2009; 39: 1098-1107. doi:10.1002/eji.200838871.
45. Zaccone P, Burton OT, Gibbs S, et al. Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems. J Biomed Biotechnol 2010; 2010: 795210. doi:10.1155/2010/795210.
46. + T cells. Eur J Immunol 2011; 41: 2709-2718. doi:10.1002/eji.201141429.
47. Imai S, Tezuka H, Fujita K. A factor of inducing IgE from a filarial parasite prevents insulin-dependent diabetes mellitus in nonobese diabetic mice. Biochem Biophys Res Commun 2001; 286: 1051-1058. doi:10.1006/bbrc.2001.5471.
48. Lund ME, O'Brien B a, Hutchinson AT, et al. Secreted proteins from the helminth Fasciola hepatica inhibit the initiation of autoreactive T cell responses and prevent diabetes in the NOD mouse. PLoS One 2014; 9: e86289. doi:10.1371/journal.pone.0086289.
49. Wiria AE, Sartono E, Supali T, Yazdanbakhsh M. Helminth infections, type-2 immune response, and metabolic syndrome. Knoll LJ, ed. PLoS Pathog 2014; 10: e1004140. doi:10.1371/journal.ppat.1004140.
50. Chawla A, Nguyen KD, Goh Yps. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol 2011; 11: 738-749. doi:10.1038/nri3071.
51. Misra A, Bhardwaj S. Obesity and the metabolic syndrome in developing countries: focus on South Asians. Nestle Nutr Inst Workshop Ser 2014; 78: 133-140. doi:10.1159/000354952.
52. Yang Z, Grinchuk V, Smith A, et al. Parasitic nematode-induced modulation of body weight and associated metabolic dysfunction in mouse models of obesity. Infect Immun 2013; 81: 1905-1914. doi:10.1128/IAI.00053-13.
53. Bhargava P, Li C, Stanya KJ, et al. Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways. Nat Med 2012: 1-9. doi:10.1038/nm.2962.
54. Cipolletta D, Kolodin D, Benoist C, Mathis D. Tissular T(regs): a unique population of adipose-tissue-resident Foxp3+CD4+ T cells that impacts organismal metabolism. Semin Immunol 2011; 23: 431-437. doi:10.1016/j.smim.2011.06.002.
55. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-184. doi:10.1172/JCI29881.
56. Winer S, Winer D. The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance. Immunol Cell Biol 2012; 90: 755-762. doi:10.1038/icb.2011.110.
57. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867. doi:10.1038/nature05485.
58. Winer D, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, Tsui H, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 2011; 17: 610-617. doi:10.1038/nm.2353.
59. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025. doi:10.1172/JCI28898.
60. Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD, Allen JE. Helminth parasites-masters of regulation. Immunol Rev 2004; 201: 89-116. doi:10.1111/j.0105-2896.2004.00191.x.
61. Hoerauf A, Satoguina J, Saeftel M, Specht S. Immunomodulation by filarial nematodes. Parasite Immunol 2005; 27: 417-429. doi:10.1111/j.1365-3024.2005.00792.x.
62. Hübner MP, Layland LE, Hoerauf A. Helminths and their implication in sepsis-a new branch of their immunomodulatory behaviour? Pathog Dis 2013; 69: 1-15. doi:10.1111/2049-632X.12080.
63. Allen JE, Maizels RM. Diversity and dialogue in immunity to helminths. Nat Rev Immunol 2011; 11: 375-388. doi:10.1038/nri2992.
64. Ricardo-Gonzalez RR, Red Eagle A, Odegaard JI, et al. IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity. Proc Natl Acad Sci U S A 2010; 107: 22617-22622. doi:10.1073/pnas.1009152108.
65. Hong E-G, Ko HJ, Cho Y-R, et al. Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes 2009; 58: 2525-2535. doi:10.2337/db08-1261.
66. Kim H, Higashimori T, Park S, et al. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 2004; 53: 1060-1067.
67. Cintra DE, Pauli JR, Araújo EP, et al. Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. J Hepatol 2008; 48: 628-637. doi:10.1016/j.jhep.2007.12.017.
68. Haben I, Hartmann W, Specht S, et al. T-cell-derived, but not B-cell-derived, IL-10 suppresses antigen-specific T-cell responses in Litomosoides sigmodontis-infected mice. Eur J Immunol 2013; 43: 1799-1805. doi:10.1002/eji.201242929.
69. Ferreira I, Smyth D, Gaze S, et al. Hookworm excretory/secretory products induce IL-4+IL-10+ CD4+ T cell responses and suppress pathology in a mouse model of colitis. Infect Immun 2013; 81: 2104-2111. doi:10.1128/IAI.00563-12.
70. Mitre E, Chien D, Nutman TB. CD4(+) (and not CD25+) T cells are the predominant interleukin-10-producing cells in the circulation of filaria-infected patients. J Infect Dis 2008; 197: 94-101. doi:10.1086/524301.
71. Hesse M, Piccirillo C a, Belkaid Y, et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 2004; 172: 3157-3166. doi:10.4049/jimmunol.172.5.3157.
72. Doetze A, Satoguina J, Burchard G, et al. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. Int Immunol 2000; 12: 623-630. doi:10.1093/intimm/12.5.623.
73. Hussaarts L, van der Vlugt Lepm, Yazdanbakhsh M, Smits HH. Regulatory B-cell induction by helminths: implications for allergic disease. J Allergy Clin Immunol 2011; 128: 733-739. doi:10.1016/j.jaci.2011.05.012.
74. Mangan Ne, Fallon Re, Smith P, van Rooijen N, McKenzie AN, Fallon Pg. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J Immunol 2004; 173: 6346-6356.
75. Velupillai P, Secor We, Hoerauf AM, Harn Da. B-1 cell (CD5+B220+) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars. J Immunol 1997; 158: 338-344.
76. Palanivel V, Posey C, Hoerauf Am, Solbach W, Piessens Wf, Harn Da. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. Exp Parasitol 1996; 84: 168-177. doi:10.1006/expr.1996.0102.
77. Blagoev B, Kratchmarova I, Nielsen MM, et al. Inhibition of adipocyte differentiation by resistin-like molecule alpha. Biochemical characterization of its oligomeric nature. J Biol Chem 2002; 277: 42011-42016. doi:10.1074/jbc.M206975200.
78. Cousin B, Cinti S, Morroni M, et al. Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J Cell Sci 1992; 103: 931-942.
79. Kajimura S, Saito M. A new era in brown adipose tissue biology: molecular control of brown fat development and energy homeostasis. Annu Rev Physiol 2013: 1-25. doi:10.1146/annurev-physiol-021113-170252.
80. Xue B, Coulter A, Rim Js, Koza Ra, Kozak Lp. Transcriptional synergy and the regulation of Ucp1 during brown adipocyte induction in white fat depots. Mol Cell Biol 2005; 25: 8311-8322. doi:10.1128/MCB.25.18.8311-8322.2005.
81. Ishibashi J, Seale P. Medicine. Beige can be slimming. Science 2010; 328: 1113-1114. doi:10.1126/science.1190816.
82. Seale P, Bjork B, Yang W, et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008; 454: 961-967. doi:10.1038/nature07182.
83. Cohen P, Levy Jd, Zhang Y, et al. Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch. Cell 2014; 156: 304-316. doi:10.1016/j.cell.2013.12.021.
84. Sellayah D, Bharaj P, Sikder D. Orexin is required for brown adipose tissue development, differentiation, and function. Cell Metab 2011; 14: 478-490. doi:10.1016/j.cmet.2011.08.010.
85. Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012; 481: 463-468. doi:10.1038/nature10777.
86. Bordicchia M, Liu D, Amri E-Z, et al. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J Clin Invest 2012; 122: 1022-1036. doi:10.1172/JCI59701.
87. Hondares E, Rosell M, Gonzalez FJ, Giralt M, Iglesias R, Villarroya F. Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. Cell Metab 2010; 11: 206-212. doi:10.1016/j.cmet.2010.02.001.
88. Rao Rr, Long Jz, White Jp, et al. Meteorin-like Is a Hormone that Regulates Immune-Adipose Interactions to Increase Beige Fat Thermogenesis. Cell 2014; 157: 1279-1291. doi:10.1016/j.cell.2014.03.065.
89. Qiu Y, Nguyen Kd, Odegaard JI, et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014; 157: 1292-1308. doi:10.1016/j.cell.2014.03.066.
90. Molofsky Ab, Nussbaum Jc, Liang H, et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med 2013; 210: 535-549. doi:10.1084/jem.20121964.
91. Brestoff Jr, Kim Bs, Saenz Sa, et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 2015; 519: 242-246. doi:10.1038/nature14115.
92. Lee M-W, Odegaard JI, Mukundan L, et al. Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 2014. doi:10.1016/j.cell.2014.12.011.
93. H2, allergy and group 2 innate lymphoid cells. 2013; 14. doi:10.1038/ni.2617.
94. Butler Ae, Janson J, Soeller Wc, Butler PC. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 2003; 52: 2304-2314.
95. Sako Y, Grill VE. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 1990; 127: 1580-1589. doi:10.1210/endo-127-4-1580.
96. Shimabukuro M, Zhou Yt, Levi M, Unger Rh. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A 1998; 95: 2498-2502.
97. Robertson Rp. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279: 42351-42354. doi:10.1074/jbc.R400019200.
98. Butler Ae, Jang J, Gurlo T, Carty Md, Soeller Wc, Butler PC. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes 2004; 53: 1509-1516.
99. Donath My, Størling J, Berchtold La, Billestrup N, Mandrup-Poulsen T. Cytokines and beta-cell biology: from concept to clinical translation. Endocr Rev 2008; 29: 334-350. doi:10.1210/er.2007-0033.
100. Fiorentino DF. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-2095. doi:10.1084/jem.170.6.2081.
101. Tahapary DL, De Ruiter K, Martin I, et al. Helminth infections and type 2 diabetes: a cluster-randomized placebo controlled SUGARSPIN trial in Nangapanda, Flores, Indonesia. BMC Infect Dis 2015; 15: 1-9. doi:10.1186/s12879-015-0873-4.